Poulam M. Patel
Oklahoma State University(US)Nottingham University Hospitals NHS Trust(GB)University of Nottingham(GB)IMS Unison University(IN)MedStar Health(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Renal and related cancers
Most-Cited Works
- → Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma(2014)428 cited
- → Proteomic analysis of melanoma‐derived exosomes by two‐dimensional polyacrylamide gel electrophoresis and mass spectrometry(2004)332 cited
- → Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study(2019)271 cited
- → IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines(2008)248 cited
- → Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)(2011)210 cited
- → Pretreatment Levels of Peripheral Neutrophils and Leukocytes As Independent Predictors of Overall Survival in Patients With American Joint Committee on Cancer Stage IV Melanoma: Results of the EORTC 18951 Biochemotherapy Trial